Influence of blood lipids on global coagulation test results

Annals of Laboratory Medicine

Volumn 35, Issue 1, 2015, Pages 15-21

  Kim, Jung Ah ^a   Kim, Ji Eun ^a   Song, Sang Hoon ^a   Kim, Hyun Kyung ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Blood coagulation factors; Blood coagulation tests; Cholesterol; Triglycerides

Indexed keywords

BLOOD CLOTTING FACTOR; CHOLESTEROL; LIPID; THROMBIN; TRIACYLGLYCEROL;

ADULT; AGED; BLOOD; BLOOD CLOTTING TEST; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; REPRODUCIBILITY; STATISTICAL MODEL;

ADULT; AGED; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CHOLESTEROL; FEMALE; HUMANS; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; REPRODUCIBILITY OF RESULTS; THROMBIN; TRIGLYCERIDES;

EID: 84920534360     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2015.35.1.15     Document Type: Article

References (21)

1. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 2005;3:2607-11.
2. Dargaud Y, Trzeciak MC, Bordet JC, Ninet J, Negrier C. Use of calibrated automated thrombinography +/-thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost 2006;96:562-7.
3. Tripodi A, Arbini A, Chantarangkul V, Mannucci PM. Recombinant tissue factor as substitute for conventional thromboplastin in the pro-thrombin time test. Thromb Haemost 1992;67:42-5.
4. Simioni P, Castoldi E, Lunghi B, Tormene D, Rosing J, Bernardi F. An underestimated combination of opposites resulting in enhanced thrombot-ic tendency. Blood 2005;106:2363-5.
5. Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006;296:397-402.
6. Brandts A, van HylckamaVlieg A, Rosing J, Baglin T P, Rosendaal FR. The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein C. J Thromb Haemost 2007;5:416-8.
7. Castoldi E, Govers-Riemslag JW, Pinotti M, Bindini D, Tans G, Berrettini M, et al. Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients ho-mozygous for the FVII 9726+5G>A (FVII Lazio) mutation. Blood 2003; 102:4014-20.
8. Osterud B and Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl AcadSci U S A 1977;74:5260-4.
9. Branchi A, Rovellini A, Sommariva D, Gugliandolo AG, Fasoli A. Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia. Thromb Haemost 1993;70:241-3.
10. Chan P, Tomlinsoin B, Tsai CW, Pan WH, Lee YS. Thrombophilia in patients with hypercholesterolemia. Metabolism 1996;45:966-9.
11. Chan P, Huang TY, Shieh SM, Lin TS, Tsai CW. Thrombophilia in patients with hypertriglyceridemia. J Thromb Thrombolysis 1997;4:425-9.
12. Bowman R, Joosen AM, Welch AA, Luben RN, Khaw KT, Wareham NJ, et al. Factor VII, blood lipids and fat intake: gene-nutrient interaction and risk of coronary heart disease with the factor VII R353Q polymorphism. Eur J Clin Nutr 2009;63:771-7.
13. Silveira A. Postprandial triglycerides and blood coagulation.Exp Clin En-docrinol Diabetes 2001;109:S527-32.
14. Undas A, Brummel-Ziedins KE, Mann KG. Statins and blood coagulation. Arterioscler Thromb Vasc Biol 2005;25:287-94.
15. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003;33:4-15.
16. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 2002; 106:3143-421.
17. Kim SY, Kim JE, Kim HK, Kim I, Yoon SS, Park S. Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults. Am J Clin Pathol 2013;139:370-9.
18. Hoffman CJ, Lawson WE, Miller RH, Hultin MB.Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb1994;14:1737-40.
19. Duchemin J, Pan-Petesch B, Arnaud B, Blouch MT, Abgrall JF. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost 2008;99:767-73.
20. Omarova F, Uitte De Willige S, Ariëns RA, Rosing J, Bertina RM, Castol-di E. Inhibition of thrombin-mediated factor V activation contributes to the anticoagulant activity of fibrinogen γ'. J Thromb Haemost 2013;11: 1669-78.
21. Mayer J, Eller T, Brauer P, Solleder EM, Schäfer RM, Keller F, et al. Effects of long-term treatment with lovastatin on the clotting system and blood platelets. Ann Hematol 1992;64:196-201.